XPRO India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: December 4, 2025, 2:03 am

Competitors of XPRO India Ltd

All Competitor Stocks of XPRO India Ltd

Quarterly Result

Last Updated: August 1, 2025, 9:05 am

Below is a detailed analysis of the quarterly data for XPRO India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 144.90 Cr.. The value appears to be declining and may need further review. It has decreased from 158.21 Cr. (Mar 2025) to 144.90 Cr., marking a decrease of 13.31 Cr..
• For Expenses, as of Jun 2025, the value is 147.42 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 148.23 Cr. (Mar 2025) to 147.42 Cr., marking a decrease of 0.81 Cr..
• For Operating Profit, as of Jun 2025, the value is -2.52 Cr.. The value appears to be declining and may need further review. It has decreased from 9.98 Cr. (Mar 2025) to -2.52 Cr., marking a decrease of 12.50 Cr..
• For OPM %, as of Jun 2025, the value is -1.74%. The value appears to be declining and may need further review. It has decreased from 6.31% (Mar 2025) to -1.74%, marking a decrease of 8.05%.
• For Other Income, as of Jun 2025, the value is 3.44 Cr.. The value appears strong and on an upward trend. It has increased from 3.08 Cr. (Mar 2025) to 3.44 Cr., marking an increase of 0.36 Cr..
• For Interest, as of Jun 2025, the value is 1.69 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.49 Cr. (Mar 2025) to 1.69 Cr., marking an increase of 0.20 Cr..
• For Depreciation, as of Jun 2025, the value is 2.98 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.77 Cr. (Mar 2025) to 2.98 Cr., marking an increase of 0.21 Cr..
• For Profit before tax, as of Jun 2025, the value is -3.75 Cr.. The value appears to be declining and may need further review. It has decreased from 8.80 Cr. (Mar 2025) to -3.75 Cr., marking a decrease of 12.55 Cr..
• For Tax %, as of Jun 2025, the value is 46.13%. The value appears to be increasing, which may not be favorable. It has increased from 25.23% (Mar 2025) to 46.13%, marking an increase of 20.90%.
• For Net Profit, as of Jun 2025, the value is -5.48 Cr.. The value appears to be declining and may need further review. It has decreased from 6.57 Cr. (Mar 2025) to -5.48 Cr., marking a decrease of 12.05 Cr..
• For EPS in Rs, as of Jun 2025, the value is -2.46. The value appears to be declining and may need further review. It has decreased from 2.95 (Mar 2025) to -2.46, marking a decrease of 5.41.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:07 am

Growth

Last Updated: September 5, 2025, 1:56 pm

Balance Sheet

Last Updated: December 4, 2025, 2:14 am

Below is a detailed analysis of the balance sheet data for XPRO India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2025) to 23.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Sep 2025, the value is 662.00 Cr.. The value appears strong and on an upward trend. It has increased from 588.00 Cr. (Mar 2025) to 662.00 Cr., marking an increase of 74.00 Cr..
• For Borrowings, as of Sep 2025, the value is 317.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 269.00 Cr. (Mar 2025) to 317.00 Cr., marking an increase of 48.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 98.00 Cr.. The value appears to be improving (decreasing). It has decreased from 113.00 Cr. (Mar 2025) to 98.00 Cr., marking a decrease of 15.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 1,100.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 993.00 Cr. (Mar 2025) to 1,100.00 Cr., marking an increase of 107.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 177.00 Cr.. The value appears to be declining and may need further review. It has decreased from 179.00 Cr. (Mar 2025) to 177.00 Cr., marking a decrease of 2.00 Cr..
• For CWIP, as of Sep 2025, the value is 427.00 Cr.. The value appears strong and on an upward trend. It has increased from 345.00 Cr. (Mar 2025) to 427.00 Cr., marking an increase of 82.00 Cr..
• For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Other Assets, as of Sep 2025, the value is 495.00 Cr.. The value appears strong and on an upward trend. It has increased from 468.00 Cr. (Mar 2025) to 495.00 Cr., marking an increase of 27.00 Cr..
• For Total Assets, as of Sep 2025, the value is 1,100.00 Cr.. The value appears strong and on an upward trend. It has increased from 993.00 Cr. (Mar 2025) to 1,100.00 Cr., marking an increase of 107.00 Cr..

Notably, the Reserves (662.00 Cr.) exceed the Borrowings (317.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for XPRO India Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 17.17. This value is within the healthy range. It has decreased from 21.81 (Mar 24) to 17.17, marking a decrease of 4.64.
• For Diluted EPS (Rs.), as of Mar 25, the value is 17.01. This value is within the healthy range. It has decreased from 21.77 (Mar 24) to 17.01, marking a decrease of 4.76.
• For Cash EPS (Rs.), as of Mar 25, the value is 21.98. This value is within the healthy range. It has decreased from 24.97 (Mar 24) to 21.98, marking a decrease of 2.99.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 273.66. It has increased from 254.38 (Mar 24) to 273.66, marking an increase of 19.28.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 273.66. It has increased from 254.38 (Mar 24) to 273.66, marking an increase of 19.28.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 240.03. It has increased from 211.22 (Mar 24) to 240.03, marking an increase of 28.81.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 31.00. This value is within the healthy range. It has decreased from 35.55 (Mar 24) to 31.00, marking a decrease of 4.55.
• For PBIT / Share (Rs.), as of Mar 25, the value is 26.06. This value is within the healthy range. It has decreased from 30.49 (Mar 24) to 26.06, marking a decrease of 4.43.
• For PBT / Share (Rs.), as of Mar 25, the value is 23.40. This value is within the healthy range. It has decreased from 27.30 (Mar 24) to 23.40, marking a decrease of 3.90.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 17.04. This value is within the healthy range. It has decreased from 19.91 (Mar 24) to 17.04, marking a decrease of 2.87.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 17.04. This value is within the healthy range. It has decreased from 19.91 (Mar 24) to 17.04, marking a decrease of 2.87.
• For PBDIT Margin (%), as of Mar 25, the value is 12.91. This value is within the healthy range. It has decreased from 16.82 (Mar 24) to 12.91, marking a decrease of 3.91.
• For PBIT Margin (%), as of Mar 25, the value is 10.85. This value is within the healthy range. It has decreased from 14.43 (Mar 24) to 10.85, marking a decrease of 3.58.
• For PBT Margin (%), as of Mar 25, the value is 9.74. This value is below the healthy minimum of 10. It has decreased from 12.92 (Mar 24) to 9.74, marking a decrease of 3.18.
• For Net Profit Margin (%), as of Mar 25, the value is 7.09. This value is within the healthy range. It has decreased from 9.42 (Mar 24) to 7.09, marking a decrease of 2.33.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.09. This value is below the healthy minimum of 8. It has decreased from 9.42 (Mar 24) to 7.09, marking a decrease of 2.33.
• For Return on Networth / Equity (%), as of Mar 25, the value is 6.22. This value is below the healthy minimum of 15. It has decreased from 7.82 (Mar 24) to 6.22, marking a decrease of 1.60.
• For Return on Capital Employeed (%), as of Mar 25, the value is 6.74. This value is below the healthy minimum of 10. It has decreased from 11.19 (Mar 24) to 6.74, marking a decrease of 4.45.
• For Return On Assets (%), as of Mar 25, the value is 3.82. This value is below the healthy minimum of 5. It has decreased from 6.47 (Mar 24) to 3.82, marking a decrease of 2.65.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.32. This value is within the healthy range. It has increased from 0.03 (Mar 24) to 0.32, marking an increase of 0.29.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.38. This value is within the healthy range. It has increased from 0.06 (Mar 24) to 0.38, marking an increase of 0.32.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.64. It has decreased from 0.91 (Mar 24) to 0.64, marking a decrease of 0.27.
• For Current Ratio (X), as of Mar 25, the value is 3.36. This value exceeds the healthy maximum of 3. It has decreased from 5.56 (Mar 24) to 3.36, marking a decrease of 2.20.
• For Quick Ratio (X), as of Mar 25, the value is 2.90. This value exceeds the healthy maximum of 2. It has decreased from 4.96 (Mar 24) to 2.90, marking a decrease of 2.06.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.30. This value is within the healthy range. It has increased from 6.81 (Mar 24) to 7.30, marking an increase of 0.49.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 11.59. This value is below the healthy minimum of 20. It has increased from 9.42 (Mar 24) to 11.59, marking an increase of 2.17.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 8.99. This value is below the healthy minimum of 20. It has increased from 7.51 (Mar 24) to 8.99, marking an increase of 1.48.
• For Earning Retention Ratio (%), as of Mar 25, the value is 88.41. This value exceeds the healthy maximum of 70. It has decreased from 90.58 (Mar 24) to 88.41, marking a decrease of 2.17.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 91.01. This value exceeds the healthy maximum of 70. It has decreased from 92.49 (Mar 24) to 91.01, marking a decrease of 1.48.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 11.66. This value is within the healthy range. It has decreased from 15.65 (Mar 24) to 11.66, marking a decrease of 3.99.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 7.41. This value is within the healthy range. It has decreased from 10.17 (Mar 24) to 7.41, marking a decrease of 2.76.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,575.63. It has increased from 2,147.95 (Mar 24) to 2,575.63, marking an increase of 427.68.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.81. This value exceeds the healthy maximum of 3. It has increased from 4.62 (Mar 24) to 4.81, marking an increase of 0.19.
• For EV / EBITDA (X), as of Mar 25, the value is 37.26. This value exceeds the healthy maximum of 15. It has increased from 27.42 (Mar 24) to 37.26, marking an increase of 9.84.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.86. This value exceeds the healthy maximum of 3. It has decreased from 5.23 (Mar 24) to 4.86, marking a decrease of 0.37.
• For Retention Ratios (%), as of Mar 25, the value is 88.40. This value exceeds the healthy maximum of 70. It has decreased from 90.57 (Mar 24) to 88.40, marking a decrease of 2.17.
• For Price / BV (X), as of Mar 25, the value is 4.27. This value exceeds the healthy maximum of 3. It has decreased from 4.34 (Mar 24) to 4.27, marking a decrease of 0.07.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.86. This value exceeds the healthy maximum of 3. It has decreased from 5.23 (Mar 24) to 4.86, marking a decrease of 0.37.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness